Bain and Cinven win €4.1bn bidding war for German drugmaker https://t.co/gpHmomZVBQ via @FT — The Propell Group (@ThePropellGroup) April 10, 2017 #healthtech
AliveCor launches clinical app with AI function for early detection of AFib to prevent stroke https://t.co/KJHYdlXQda
0 0
AliveCor launches clinical app with AI function for early detection of AFib to prevent stroke https://t.co/KJHYdlXQda — The Propell Group (@ThePropellGroup) April 10, 2017 #healthtech
Another reason to consider South Korea’s ‘creative economy’ https://t.co/n5ojSkC4Xp — The Propell Group (@ThePropellGroup) April 9, 2017 #healthtech
When it Comes to Cancer, Big Data is So Small, It’s Family https://t.co/IhdXkQp2eQ — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
Fresenius confirms it’s weighing a bid for generic drugmaker Akorn https://t.co/ukTMzQ6H7p via @FT
0 0
Fresenius confirms it’s weighing a bid for generic drugmaker Akorn https://t.co/ukTMzQ6H7p via @FT — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
Hive wants to automate crop-dusting for China’s farmers https://t.co/llN2xPS5vh — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
Holmusk collaborates with Singapore to manage cardio diseases – BioSpectrum Asia https://t.co/uQNfNOd3g1
0 0
Holmusk collaborates with Singapore to manage cardio diseases – BioSpectrum Asia https://t.co/uQNfNOd3g1 — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
The State Of Synthetic Biology: Investors Placing Bets In Food, Biofuel, Healthcare, And More https://t.co/wEblcTDVFc
0 0
The State Of Synthetic Biology: Investors Placing Bets In Food, Biofuel, Healthcare, And More https://t.co/wEblcTDVFc — The Propell Group (@ThePropellGroup) April 7, 2017 #healthtech
Dubai 100 launches European Bootcamp in London – as Dubai Pitch Day draws near https://t.co/mvVsGzYnhl
0 0
Dubai 100 launches European Bootcamp in London – as Dubai Pitch Day draws near https://t.co/mvVsGzYnhl — The Propell Group (@ThePropellGroup) April 7, 2017 #healthtech
FDA clears consumer genetic tests in victory for 23andMe https://t.co/6W0mQ0bLNu via @FT — The Propell Group (@ThePropellGroup) April 7, 2017 #healthtech